 Stephani Stancil
Concepts (110)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Naltrexone | 3 | 2022 | 4 | 2.420 |
Why?
| | Narcotic Antagonists | 2 | 2021 | 3 | 1.540 |
Why?
| | Contraceptive Agents | 2 | 2021 | 15 | 1.360 |
Why?
| | Metronidazole | 2 | 2019 | 14 | 1.340 |
Why?
| | Adolescent | 14 | 2024 | 2087 | 1.340 |
Why?
| | Humans | 18 | 2024 | 6599 | 1.150 |
Why?
| | Contraception | 4 | 2023 | 33 | 1.140 |
Why?
| | Opioid-Related Disorders | 2 | 2021 | 15 | 0.990 |
Why?
| | Female | 13 | 2023 | 3436 | 0.970 |
Why?
| | Anticonvulsants | 1 | 2024 | 25 | 0.970 |
Why?
| | Stevens-Johnson Syndrome | 1 | 2024 | 13 | 0.960 |
Why?
| | Microsomes, Liver | 1 | 2023 | 42 | 0.930 |
Why?
| | Adult | 8 | 2023 | 1233 | 0.920 |
Why?
| | Food-Drug Interactions | 1 | 2022 | 1 | 0.890 |
Why?
| | Liver | 1 | 2023 | 119 | 0.880 |
Why?
| | Adolescent Psychiatry | 1 | 2022 | 3 | 0.850 |
Why?
| | Anxiety Disorders | 1 | 2022 | 21 | 0.830 |
Why?
| | Nitroimidazoles | 1 | 2021 | 1 | 0.820 |
Why?
| | Young Adult | 7 | 2023 | 652 | 0.820 |
Why?
| | Antitubercular Agents | 1 | 2021 | 7 | 0.820 |
Why?
| | Tuberculosis, Multidrug-Resistant | 1 | 2021 | 2 | 0.820 |
Why?
| | Child | 7 | 2024 | 3146 | 0.810 |
Why?
| | Clinical Decision-Making | 1 | 2020 | 20 | 0.770 |
Why?
| | Male | 9 | 2024 | 3197 | 0.760 |
Why?
| | Bulimia Nervosa | 1 | 2019 | 1 | 0.720 |
Why?
| | Binge-Eating Disorder | 1 | 2019 | 1 | 0.720 |
Why?
| | Cytochrome P-450 CYP2A6 | 1 | 2019 | 3 | 0.700 |
Why?
| | Nicotine | 1 | 2019 | 11 | 0.700 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2018 | 41 | 0.650 |
Why?
| | Tandem Mass Spectrometry | 1 | 2018 | 19 | 0.650 |
Why?
| | Abnormalities, Drug-Induced | 1 | 2015 | 9 | 0.560 |
Why?
| | Adolescent Health Services | 3 | 2021 | 14 | 0.530 |
Why?
| | Counseling | 1 | 2015 | 60 | 0.530 |
Why?
| | Middle Aged | 3 | 2021 | 648 | 0.470 |
Why?
| | Cytosol | 2 | 2023 | 13 | 0.450 |
Why?
| | Metabolic Clearance Rate | 2 | 2023 | 18 | 0.450 |
Why?
| | Pregnancy | 4 | 2021 | 203 | 0.400 |
Why?
| | Cross-Over Studies | 2 | 2022 | 32 | 0.400 |
Why?
| | Retrospective Studies | 3 | 2020 | 1251 | 0.360 |
Why?
| | Drug Prescriptions | 2 | 2020 | 22 | 0.330 |
Why?
| | Hospitals, Pediatric | 2 | 2020 | 178 | 0.320 |
Why?
| | United States | 3 | 2021 | 646 | 0.320 |
Why?
| | Electronic Health Records | 2 | 2021 | 61 | 0.320 |
Why?
| | Feasibility Studies | 3 | 2023 | 66 | 0.300 |
Why?
| | Pregnancy, Unplanned | 2 | 2023 | 9 | 0.260 |
Why?
| | HLA-B Antigens | 1 | 2024 | 7 | 0.250 |
Why?
| | Sexual Behavior | 2 | 2021 | 40 | 0.240 |
Why?
| | Proteins | 1 | 2023 | 22 | 0.240 |
Why?
| | Adolescent Behavior | 2 | 2021 | 47 | 0.230 |
Why?
| | Models, Biological | 1 | 2023 | 46 | 0.230 |
Why?
| | Pregnancy in Adolescence | 1 | 2023 | 5 | 0.230 |
Why?
| | Area Under Curve | 1 | 2022 | 34 | 0.220 |
Why?
| | Health Education | 1 | 2023 | 39 | 0.220 |
Why?
| | Emergency Service, Hospital | 2 | 2021 | 129 | 0.220 |
Why?
| | Pharmacogenetics | 1 | 2024 | 170 | 0.210 |
Why?
| | Harm Reduction | 1 | 2021 | 4 | 0.210 |
Why?
| | Biotransformation | 1 | 2021 | 49 | 0.210 |
Why?
| | Extensively Drug-Resistant Tuberculosis | 1 | 2021 | 1 | 0.210 |
Why?
| | Anxiety | 1 | 2022 | 45 | 0.210 |
Why?
| | Infant, Newborn | 2 | 2021 | 790 | 0.200 |
Why?
| | Drug Therapy, Combination | 1 | 2021 | 38 | 0.200 |
Why?
| | Biomarkers | 1 | 2022 | 120 | 0.200 |
Why?
| | Employment | 1 | 2021 | 4 | 0.200 |
Why?
| | Attitude | 1 | 2021 | 12 | 0.200 |
Why?
| | Insurance, Health | 1 | 2021 | 17 | 0.200 |
Why?
| | Genotype | 1 | 2022 | 395 | 0.200 |
Why?
| | Obsessive-Compulsive Disorder | 1 | 2020 | 6 | 0.200 |
Why?
| | Prescription Drugs | 1 | 2020 | 4 | 0.190 |
Why?
| | Academic Medical Centers | 1 | 2020 | 9 | 0.190 |
Why?
| | Esophagitis | 1 | 2020 | 7 | 0.190 |
Why?
| | Gastritis | 1 | 2020 | 8 | 0.190 |
Why?
| | Patient Acceptance of Health Care | 1 | 2021 | 44 | 0.190 |
Why?
| | Aged | 1 | 2021 | 375 | 0.190 |
Why?
| | Attention Deficit Disorder with Hyperactivity | 1 | 2020 | 17 | 0.190 |
Why?
| | Motivational Interviewing | 1 | 2021 | 52 | 0.190 |
Why?
| | Cytochrome P-450 CYP2C19 | 1 | 2020 | 54 | 0.190 |
Why?
| | Cytochrome P-450 CYP3A | 1 | 2020 | 46 | 0.190 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2020 | 92 | 0.190 |
Why?
| | Depression | 1 | 2020 | 68 | 0.180 |
Why?
| | Off-Label Use | 1 | 2019 | 5 | 0.180 |
Why?
| | Vomiting | 1 | 2019 | 23 | 0.180 |
Why?
| | Animals | 1 | 2021 | 563 | 0.180 |
Why?
| | Healthy Volunteers | 1 | 2019 | 8 | 0.170 |
Why?
| | Reproductive Health Services | 1 | 2019 | 3 | 0.170 |
Why?
| | Hospitalists | 1 | 2019 | 9 | 0.170 |
Why?
| | Sequence Analysis, DNA | 1 | 2019 | 106 | 0.170 |
Why?
| | Polymorphism, Genetic | 1 | 2019 | 89 | 0.170 |
Why?
| | Drug Stability | 1 | 2018 | 3 | 0.170 |
Why?
| | Limit of Detection | 1 | 2018 | 4 | 0.170 |
Why?
| | Attitude of Health Personnel | 1 | 2019 | 49 | 0.170 |
Why?
| | Decision Support Systems, Clinical | 1 | 2018 | 18 | 0.170 |
Why?
| | Linear Models | 1 | 2018 | 55 | 0.160 |
Why?
| | Cytochrome P-450 CYP2D6 | 1 | 2020 | 180 | 0.160 |
Why?
| | Practice Patterns, Physicians' | 1 | 2019 | 82 | 0.160 |
Why?
| | Reproducibility of Results | 1 | 2018 | 197 | 0.160 |
Why?
| | Infant | 1 | 2021 | 1396 | 0.150 |
Why?
| | Child, Preschool | 1 | 2021 | 1459 | 0.150 |
Why?
| | Teratogens | 1 | 2015 | 5 | 0.140 |
Why?
| | Pilot Projects | 2 | 2023 | 124 | 0.100 |
Why?
| | Program Evaluation | 1 | 2023 | 52 | 0.060 |
Why?
| | Contraception Behavior | 1 | 2020 | 11 | 0.050 |
Why?
| | Health Services Accessibility | 1 | 2020 | 34 | 0.050 |
Why?
| | Missouri | 1 | 2020 | 78 | 0.050 |
Why?
| | Pregnancy Complications | 1 | 2019 | 8 | 0.040 |
Why?
| | Risk | 1 | 2019 | 40 | 0.040 |
Why?
| | Health Care Surveys | 1 | 2019 | 32 | 0.040 |
Why?
| | Clinical Competence | 1 | 2019 | 32 | 0.040 |
Why?
| | Quality Improvement | 1 | 2018 | 60 | 0.040 |
Why?
| | Cross-Sectional Studies | 1 | 2019 | 317 | 0.040 |
Why?
| | Surveys and Questionnaires | 1 | 2018 | 290 | 0.040 |
Why?
|
|
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|